At Last We Are Closer Than Ever To Cure HIV Virus With This New Therapy SHARE IT!

The information is based on the scientific evidence of GESIDA (AIDS Study Group in Spain) we share the data that speak of its efficacy and safety.

The wonderful discovery is a treatment called antiretroviral therapy (ART). These are medicines that treat HIV. These drugs do not kill the virus completely, but when taken together, they can prevent the virus from reproducing.

It is a breakthrough in science quite effective and it is predicted that by 2020 the total cure of this disease can be developed.

HIV therapy usually includes three HIV drugs in general. The combination of these drugs for HIV is designed to keep the virus at undetectable levels and at the same time reduce the risk of transmission.

* When should I start treatment for HIV?

Treatment with anti-HIV drugs known as antiretroviral therapy or ART is recommended for all people with HIV-positive. And it helps infected people live a longer, healthier life and reduce the risk of HIV transmission.

People with HIV in the following situations should consider initiating antiretroviral therapy immediately:

-Pregnancy
-HIV-Related Illnesses and Co-Infections
-HIV Early Infection

– Pregnancy

All HIV positive pregnant women should take anti-HIV drugs to prevent mother-to-child transmission of the virus. Medicines to fight this virus will also protect the health of pregnant women.

In general, women who take HIV medications when they become pregnant should continue to take them during pregnancy. If you are diagnosed with HIV infection during pregnancy, you should consider starting the ART immediately.

– HIV-Related Illnesses and Co-Infections

Some diseases that occur in HIV-infected persons increase the need for therapy (ART). These include kidney disease and certain HIV-related opportunistic infections. Opportunistic infections occur more often and are more severe in people with weakened immune systems, such as those who have contracted HIV infection.

Acquired immunodeficiency syndrome (AIDS) is the most advanced stage of HIV infection. People with AIDS should start taking ART right away. These are life-threatening infections and cancers for people with HIV. Certain forms of cervical cancer and tuberculosis are examples of conditions characteristic of AIDS.

The diagnosis of AIDS is based on the following criteria: A CD4 lymphocyte count (cells) below 200 / mm3. A low CD4 lymphocyte count is a sign that HIV has caused severe damage to the immune system.

People with HIV and certain other infections, such as hepatitis B virus or hepatitis C, should consider initiating ART immediately.

– Early infection by HIV

Early HIV infection is the period of up to 6 months after HIV infection. During that period, the concentration of HIV in the body called viral load is very high. A high viral load causes damage to the immune system and increases the risk of HIV transmission.

Several studies indicate that even in cases of early HIV infection, ART can improve health and prolong life. ART initiated in that period reduces the risk of virus transmission. For these reasons, people with early HIV infection should consider initiating ART immediately.

* Why is it important to comply with the treatment?

Antiretroviral therapy is a lifelong treatment that helps people with HIV live longer and healthier lives. However, their effectiveness depends on compliance, ie taking HIV drugs every day, exactly as they have been prescribed. Compliance with an HIV treatment regimen prevents the virus from multiplying and destroying the immune system.

Before starting to take ART, it is important to address some issues that may make compliance difficult. For example, a busy schedule or lack of health insurance to cover the cost of medications may prevent you from taking it continuously. Health care providers can recommend resources to help people cope with issues that may prevent them from adhering to treatment.

Be Sociable, Share!

Be the first to comment

Leave a Reply

Your email address will not be published.


*